Table 5. Prognostic factors associated with in-hospital death in the non-immunocompromised group.
Variables | OR | 95% CI | P |
---|---|---|---|
Age | 1.047 | 0.958–1.144 | 0.314 |
Male | 0.143 | 0.010–1.995 | 0.148 |
Cardiovascular disease | 0.222 | 0.017–2.970 | 0.256 |
White blood cell | 1.000 | 1.000–1.000 | 0.640 |
C-reactive protein | 1.070 | 0.911–1.258 | 0.408 |
Lactate dehydrogenase | 1.002 | 0.999–1.005 | 0.201 |
AaDO2 | 1.000 | 0.994–1.007 | 0.892 |
P/F ratio | 1.008 | 0.971–1.047 | 0.677 |
Duration between admission and anti-PCP treatment | 1.044 | 0.978–1.116 | 0.195 |
AaDO2, alveolar-arterial oxygen pressure difference; CI, confidence interval; OR, odds ratio; PCP, Pneumocystis jirovecii pneumonia; P/F, PaO2/FiO2.